Eddie Joe Sullivan bought $1,531 of SABS
Chief Executive Officer at SAB Biotherapeutics, Inc.. 1,740 shares at an average of $0.88, traded Dec 7, 2023, filed Dec 8, 2023.
Score components
- +25RoleCEO
- 0Trade size$2k at market
- -5Relative to holdingsUnder 1% of holdings (0.0%)
- 0Price contextNo price history yet
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-23-068922, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 7, 2023 | POpen-market purchase Common Stock | +1,740 | $0.88 | $1,531 | 5,232,304 | Dec 8, 2023 |
Related signals
Other insiders at SAB Biotherapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | SAB Biotherapeutics, Inc. | Michael King CHIEF FINANCIAL OFFICER | $4,500 5,000 shares | - | |
| 38Weak | SAB Biotherapeutics, Inc. | Samuel J Reich Executive Chairman | $9,842 11,000 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.